Evolv Technologies Holdings financials
$4.71+1.29%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $145.9M | $103.9M | $79.6M | $52.7M | $23.4M |
| Gross profit | $75.3M | $59.5M | $31.9M | $1.4M | $4.0M |
| Gross margin | 51.6% | 57.2% | 40.1% | 2.7% | 17.2% |
| Operating income | -$48.5M | -$82.3M | -$90.1M | -$103.0M | -$55.3M |
| Net income | -$33.1M | -$54.0M | -$108.0M | -$86.8M | -$10.9M |
| Net margin | −22.7% | −52.0% | −135.8% | −164.6% | −46.5% |
| Diluted EPS | $-0.20 | $-0.34 | $-0.72 | $-0.60 | $-0.15 |
| EBITDA | -$21.5M | -$63.8M | -$80.0M | -$96.3M | -$50.5M |
| Operating cash flow | $18.7M | -$30.9M | -$9.8M | -$74.7M | -$56.8M |
| Free cash flow | -$12.7M | -$62.0M | -$78.9M | -$96.2M | -$73.3M |
| Diluted shares | 168.4M | 156.6M | 149.2M | 143.9M | 71.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $49.1M | $37.0M | $67.2M | $229.8M | $307.5M |
| Short-term investments | $19.9M | $14.9M | $51.3M | $0.00 | — |
| Total debt | $28.6M | $0.00 | $0.00 | $29.7M | $9.9M |
| Total assets | $304.4M | $268.1M | $297.1M | $348.1M | $362.9M |
| Total liabilities | $185.0M | $150.4M | $153.0M | $115.0M | $61.6M |
| Shareholders' equity | $119.4M | $117.7M | $144.1M | $233.1M | $301.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology